precursor 25 hydroxy cholecalciferol. Only recently, its crucial role as a potential immune modulator has been recognized. Clear identification of its well-documented roles in immune response and autoimmunity has led it to being actively pursued as a potential therapeutic agent. 1, 2 Vitamin D3 influences all the key cells of the immune system and produces intracrine and paracrine effects on them. Most immune cells have the enzyme system to produce the active form of vitamin D3. It is an inhibitor of differentiation and maturation of dendritic cells (DCs) and decreases their antigen-presenting activity. It acts directly on T cells and alters the profile of their proliferation and differentiation. It promotes anti-inflammatory environment by inhibiting the Th1 and Th17 cells and promoting the Th 2 and T reg cell differentiations. Vitamin D3 induces antimicrobial effects in monocytes/macrophages by enhancing their phagocyte activity as well as helping the synthesis of antimicrobial peptides. Sunlight-mediated epidermal expression of 1,25(OH) 2 D3 acts as the link between the environment and immune system. It induces suppression of cutaneous immune response through the T-regulatory cells. Overall, it is considered an important regulator of both innate and adaptive immune systems. There is an emerging view that the vitamin D deficiency, which is widely prevalent these days, could have an important role in immune disorders, especially the autoimmune diseases.
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RevIew aRtIcle 10 .5005/jp-journals-10054-0043 precursor 25 hydroxy cholecalciferol. Only recently, its crucial role as a potential immune modulator has been recognized. Clear identification of its well-documented roles in immune response and autoimmunity has led it to being actively pursued as a potential therapeutic agent. 1, 2 Vitamin D3 influences all the key cells of the immune system and produces intracrine and paracrine effects on them. Most immune cells have the enzyme system to produce the active form of vitamin D3. It is an inhibitor of differentiation and maturation of dendritic cells (DCs) and decreases their antigen-presenting activity. It acts directly on T cells and alters the profile of their proliferation and differentiation. It promotes anti-inflammatory environment by inhibiting the Th1 and Th17 cells and promoting the Th 2 and T reg cell differentiations. Further, vitamin D3 represses the transcription of the key proinflammatory Th1 cytokines like interferon (IFN)-γ and interleukin (IL)-2. The B cells show significant changes under the influence of vitamin D3, including the differentiation into plasma cells and memory cells and the secretions of immunoglobulins. 2 Vitamin D3 induces antimicrobial effects in monocytes/macrophages by enhancing their phagocyte activity as well as helping the synthesis of antimicrobial peptides. Sunlight-mediated epidermal expression of 1,25(OH) 2 D3 acts as the link between the environment and immune system. It induces suppression of cutaneous immune response through the T-regulatory cells. Overall, it is considered an important regulator of both innate and adaptive immune systems. There is an emerging view that the vitamin D deficiency, which is widely prevalent these days, could have an important role in immune disorders, especially the autoimmune diseases. 2 In this review, we present an overview of the current knowledge on vitamin D as an immunomodulator with the underlying molecular mechanisms and its possible role in immunological response with future implications.
VITAMIN D-THE MOLECULE
Ergocalciferol, vitamin D2, and cholecalciferol, vitamin D3, are the two major forms of vitamin D. Vitamin D2 is synthesized by plants and fungi, while vitamin D3 is produced in large quantities in humans by photosynthesis in the skin. The ultraviolet (UV) light falling on the skin catalyzes the conversion of 7-dehydro-cholesterol into the previtamin D, which then spontaneously
INTRODUCTION
Vitamin D has been synonymous with bone health and disease for a very long time. However, now, it is recognized as a pleotropic hormone with multiple roles on many tissues and organs. More than 25 years ago, vitamin D was touted as an immunomodulator based on the findings that macrophages and monocytes from the patients of sarcoidosis synthesized 1,25(OH) 2 D3 from its IJMB isomerizes into cholecalciferol. This is bound by the vitamin D-binding protein (DBP) and transported to the liver. To act biologically, vitamin D3 is hydroxylated at two positions-first at the 25th position in the liver catalyzed by 25 hydroxylase to make 25 
VITAMIN D3 AND IMMUNE CELLS
The VDRs are found on most immune cells like monocytes, macrophages, DCs, B cells, T cells, etc., and vitamin D has pleotropic effects on the immune system. 9 The VDR activation and signaling in immune cells were shown to result in the antiproliferative, prodifferentiation, and immunomodulatory effects. Vitamin D3 has suppressive effects on NF-kB signaling pathways in T cells, monocytes, and macrophages, 10 but not in B cells. Similarly, the transcription of many other regulatory factors by 1,25(OH) 2 D3 has been evaluated. All these finding indicate the differential actions of vitamin D3 on these cells.
VITAMIN D3 AND MONOCYTE/MACROPHAGES
One of the earliest studies linking vitamin D3 and immunity was the enhancement of antibacterial response of monocytes and macrophages by 1,25(OH) 2 D3. Recently, the monocytes/macrophages isolated from sarcoidosis granuloma or from the alveolar levage fluid were shown to have 1α hydroxylase activity capable of synthesizing 1,25(OH) 2 D3 from 25-OH D3. 11 Subsequently, this was shown in other granulomatous diseases and cancers also. 12 Human peripheral blood mononuclear cells also synthesize 1,25(OH) 2 D3 in response to immune stimuli, such as IFN-γ or bacterial antigens agonists of TLRs, such as lipopolysaccharides. Both these stimuli induce the expression of CYP27B1 in activated macrophages. 13 In culture studies of human macrophages, increased antimicrobial activity has also been demonstrated following TLR stimulation with lipopolysaccharides. African-Americans, who are more prone to tuberculosis, had low 25-OH D3 levels and were less efficient in antimicrobial activity induction. This was in contrast to white Americans who had higher vitamin D3 levels. 14 Treatment of human monocytes with 1,25(OH) 2 D3 not only suppresses the expression of both TLR-2 and TLR-4 in a dose-and time-dependent manner, but also promotes the antimicrobial activity of the myeloid cells. This appears contradictory and results in a state of hyporesponsiveness. 15 Subsequently, it was found to be part of a negative feedback mechanism, which prevented the excessive TLR activation and inflammation in the later stage of infection. This could be brought about by calcitriol by decreasing or preventing the release of inflammatory cytokines by the macrophages. Calcitriol directly induces the expression of other innate pathogen recognition receptors like NOD2/CARD15/ IBD1 in monocytes and leads to the expression of antimicrobial peptide defensin β2 through NF-kB pathway after activation by their natural ligands. 16 Prolonged signaling in macrophages is induced and maintained over an extended period by 1,25(OH) 2 D3 and is considered advantageous for combating the intracellular pathogen like Mycobacterium tuberculosis. 17 It is explained based on the presence of defective negative feedback loop mediated in macrophages by an alternatively spliced and inactive variant of 24 hydroxylase. 18 Signaling also suppress the induction of matrix metalloproteinase 7, 9, and 10 in peripheral blood mononuclear cells infected with M. tuberculosis. 19 Calcitriol also enhances the secretion of IL-10, prostaglandin E-2, and the antibacterial peptide cathelicidin 20 in human myeloid cells. This peptide has a direct antimicrobial and antiviral effect on the invading organisms. This localized synthesis of 1,25(OH) 2 D3 promotes pathogen killing and may also involve induced nitric oxide, iNO.
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VITAMIN D3 AND DCs
Different subsets of DCs have different origins, phenotype, and functions being derived from both myeloid precursors, the myeloid DCs (mDCs) and from lymphoid precursors, the plasmacytoid DCs (pDCs). They produce cytokines and have a critical role in T-cell responses. The mDCs are important as antigen-presenting cells (APCs) while pDCs are involved with the immune tolerance. Most of these effects are shown in in vitro studies using very high exogenous and nonphysiological doses of vitamin D3. It role is doubtful at physiological concentrations. It is argued that the local intracrine synthesis of 1,25(OH) 2 D3 may be effective in achieving these responses. The vitamin D3 exerts its effects on human mDCs by inhibiting the activation through NF-kB. 26 The plasmacytoid DCs show similar response and vitamin D3 synthesized by them promotes tolerance through paracrine effects on VDR-positive T cells.
VITAMIN D3 AND B CELLS
Human primary B cells constitutively express VDRs at low levels, which are upregulated on stimulation in presence of vitamin D3. 27 The CYP27B1 messenger RNA is also expressed by resting B cells in humans, and it is further enhanced on their stimulation, but vitamin D3 has no effect. 40 and decreases IL-17 mediated experimentally induced acute colitis in mouse model. 41 Further, TGF-β1 has a dose-dependent response on T H 17 cells differentiation, which is promoted at lower concentrations and suppressed at higher concentrations through the modulation of Foxp3 expression. 42 All these studies confirm the suppression of T H 17 cell development by calcitriol through the upregulation of TGF-β1.
Recent studies indicate that all T H 17 cells are not pathogenic. 43 In fact, TGF-β1-and IL-6-induced T H 17 cells are not pathogenic and do not induce tissue inflammation unless they are further exposed to IL-23. This is critical for TGF-β1 expression and pathogenicity. Further, the inhibition of IL-23 by calcitriol results in decreased inflammation in an animal model. 41 The T H 17A secretion is regulated at the transcription level and calcitriol suppresses it as well as T H 17 cell function. 44 Human studies including cell culture with calcitriol and vitamin D 3 supplementation resulting in higher serum levels have shown reduction in T H -17 cells. 45 However, the findings are not equivocal and conflicting in human studies.
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T REG CELLS
The T reg cells are defined functionally by their ability to suppress and limit the overactivation of effector T cells and, thereby, prevent autoimmune diseases. 47 There are several types of them and CD4 + FoxP
3+
T cells are the most intensely studied. One of these CD4 + FoxP 3+ cell subsets arises from the thymus called thymic or natural T reg cells (nT reg ) and another arises during TCR engagement in the periphery, the peripheral or induced T reg cells (iT reg ). 48 Upon activation by CD3 stimulation and costimulation with compliment regulator CD46 in presence of IL-2, CD4 + T reg cells undergo rapid proliferation and secrete large amounts of IL-10 and TGF β to induce immune suppression. 49 They also induce APC cell lysis through granzymes leading to T-cell activity termination. Ground-breaking animal model studies showed the involvement of calcitriol in T reg cell activity. The UV exposure of skin enhanced the immunity to pathogens and induced peripheral tolerance by promoting iT reg cell development through a calcitriol-and VDR-dependent mechanism in keratinocytes, which have a complete vitamin D metabolism capability. 50 In animal studies, cutaneously applied calcipotriol, a synthetic vitamin D analog, mimicked cutaneous UV exposure and led to the IL-10 producing T reg cells by similar mechanism.
51
The IL-10 is an important anti-inflammatory cytokine that protects many tissues from immune-mediated pathology. 52 57, 58 and their suppressive activity in multiple sclerosis (MS) patients. 46 Contradictory results were seen in infants whose 25-OH D3 levels did not correlate with the T reg cells.
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VITAMIN D3 AND CD8 + T CELLS
The CD8 + T cells, on activation, produce main effector cells of cellular arm of adaptive immunity to eliminate abnormal cells like those with infections, cancers, and genetic abnormalities by inducing apoptosis. In addition, they produce cytokines, which modify the activity of other immune cells. 
UNCONVENTIONAL T CELLS
Mucosa-associated invariant T cells (MAIT), γδ TCR + T cells, and natural killer (NK)T cells are called as unconventional T cells because they do not express either CD4 or CD8 like the usual T cells. The MAIT cells are believed to be immuno-suppressive as far as autoimmunity is concerned. 65 However, the effects of vitamin D3 on them remain unknown. The γδ TCR + T cells respond to phosphor-antigen and act rapidly to infections. They are shown to have pathogenic role in the animal models of autoimmune disorders like EAE and collagen-induced arthritis (CIA). They produce proinflammatory cytokines like IL-17A, IL-17F, Granulocyte-macrophage colonystimulating factor, and IFN-.γ. 66 They express VDR on activation, and in presence of vitamin D3 show inhibition of proliferation and IFN-γ secretion. 67 Currently, it is believed that their main role in autoimmunity is via the secretion of IL-17A. 66 But again, the effect of vitamin D on IL-17A is not known. The NKT cells recognize glycolipids and give protection against a wide variety of bacteria, viruses, and fungi. Upon TCR activation, they produce inflammatory cytokines including IL-4, IFN-γ, and IL-17A. They have pathogenic role in CIA, but show a protective role in EAE, type I diabetes, and systemic lupus erythematosus (SLE). 68 These cells require VDRs in thymus for development and are found hyporesponsive following TCR stimulation in VDR −/− mice. 69 The protective effect of 1,25(OH) 2 D3
partially depends on iNKT cells, possibly by inducing IL-4 secretion.
INNATE LYMPHOID CELLS
Recently, a new group of cells called innate lymphoid cells (ILC) have been identified. They are of three: (i) ILC-1 that secretes IFN-γ and depends on T_bet expression; (ii) ILC-2 IJMB that secretes group II cytokines-IL-5, IL-13 and depends on GATA 3 expression, and (iii) ILC-3 that secretes IL-17A and/or IL-22 and depends on RORC-RAR related orphan receptor C (RAR-Retenoic acid receptor) expression. The ILC-1 includes NK cells, which protect against viruses. They have both protective and pathogenic roles in autoimmunity. 70 The 1,25(OH) 2 D3 show variable effects on them, but specifically inhibit their activation, cytotoxicity, and proinflammatory cytokines secretion by the overactive NK cells. 71 The ILC-3s are believed to be pathogenic in autoimmunity. Increased ILC-3s are reported in skin lesion from the psoriasis patients, 72 in intestine in Crohn's disease, 73 In peripheral blood of MS patients, 74 and in the gut, blood, bone marrow, and synovial fluid of joints in ankylosing spondylitis. 75 They have an overall anti-inflammatory effect. 27 Initially, calcitriol was thought to mediate these effects through T H cell subsets; recent findings indicate that it exerts additional direct effects on B cells also, including the development of plasma cells and memory cells. T cell is also the target of vitamin D3 for immunomodulation. 35 Four major mechanisms of calcitriol influencing T cells proposed are: (1) direct effects due to systemic calcitriol levels; (2) intracrine effects due to the synthesis of calcitriol by the T cells; (3) paracrine effects of the APCs, which also synthesizes calcitriol, and (4) indirect effects due to changes in the APC, which present less antigen. As already said, calcitriol induces the more immature and tolerogenic forms of monocytes during their differentiation and maturation into DCs. The overall effects of calcitriol can be summarized as follows: (1) It suppresses the cytokines produced by them, (2) it promotes T H 2 anti-inflammatory cytokine environment by inhibiting proinflammatory cytokines, (3) it inhibits Th17 cell activity including the Th17 cytokines, and (4) it promotes T reg cells development. Taken together, calcitriol supports and regulates adaptive immunity in addition to innate response. Overall, it promotes anti-infective, antiinflammatory, and tolerogenic immune response.
VITAMIN D AND INNATE IMMUNITY
CONCLUSION
Vitamin D, known earlier for its role in calcium, phosphorus, and skeletal metabolism, has emerged as a key modulator of immune response. It is now clearly known that all cells of the immune system synthesize 1,25 dihydroxy D3 and express VDRs, which make responses to Vitamin D3. Consequently, the significantly high local concentrations of vitamin D3 are achieved, which produce autocrine as well as paracrine functions in addition to well-known endocrine effects. Vitamin D influences the activity of all the major cells involved in immunity. It activates the anti-infective mechanisms of innate immunity and blunts the inflammatory state. Furthern it overall suppresses the adaptive immunity by inhibiting the function of DCs, Th1, Th17 cells, and promoting T H 2 and T reg cells. It also suppresses the B-cell activity including the immunoglobulin secretion. Together, it leads to an anti-infective, anti-inflammatory, and suppressed adaptive immune response state. With increasing understanding of its role in immunity, and widely prevalent vitamin D deficiency, its role is being noticed more in immunological disorders, especially, in autoimmunity and the prevention of infections. Already vitamin D and its analogues are being explored of its therapeutic potential.
FUTURE DIRECTION
The immunomodulatory role of vitamin D3 led to exploration of its possible beneficial role in immune disorders, especially in autoimmune disorders. It was further propelled by the finding that supplementation of 1,25(OH) 2 D3 could prevent the initiation as well as progression of autoimmune diseases in experimental animal models.
Autoimmune disorders represent an abnormal state of immune system in which it fails to discriminate between the self and non-self adequately and consequently, it attacks the innocuous self-antigens resulting in inflammation, tissue damage, and loss of function with widely variable clinical manifestations. More than 100 autoimmune syndromes are known, of which the more common ones are rheumatic arthritis, MS, type I diabetes mellitus (T1DM), Crohn's disease, SLE, irritable bowel syndrome (IBD), etc. These autoimmune diseases affect large populations and the global burden has nearly tripled in the last half century, representing a considerable strain on human and economic resources worldwide. This necessitates the investigation of new avenues for their better management.
In the last few decades, numerous studies have shown a relationship between vitamin D3 and the incidence and severity of autoimmune disease, such as MS, T1DM, and IBD. In view of the weak genetic linkages with low susceptibility, the emphasis has been on finding modifiable environmental factors that act on susceptible genotype to produce disease phenotypes. The key questions being explored are: (i) what are the dominant environmental stressors, (ii) by what mechanisms do they act, and (iii) if they can lead to an etiology-based preventive and therapeutic strategies. Vitamin D appears to be promising, but needs to be further explored before its therapeutic use is established.
